Advertising in Research Reviews: A Journal of Immunology — Rates, Formats, and Why It Matters for Healthcare Brands in India

Most pharmaceutical and biotech marketing teams we speak with have never seriously considered immunology journal advertising as a media channel — which is, frankly, one of the more surprising blind spots we encounter in healthcare media planning. The brands that do advertise in peer-reviewed publications like Research & Reviews: A Journal of Immunology often report that the quality of attention they receive from readers is categorically different from what a banner ad or a trade magazine placement delivers. There is something about the context of a scientific journal — where the reader is already in a mode of deep professional engagement — that makes brand recall work differently, and the advertising rates for this channel are, in our experience, far more accessible than most marketing managers expect.

What Is Research & Reviews: A Journal of Immunology and Who Reads It?

Research & Reviews: A Journal of Immunology, commonly referred to in media planning circles as RRJoI, is a triannual peer-reviewed journal published by STM Journals, which is the publishing arm of Consortium e-Learning Network Pvt. Ltd., headquartered in Noida, Uttar Pradesh. The journal operates as an open access journal, which means its content is freely available to readers globally — a distribution model that has significant implications for advertisers, because it removes the paywall barrier that limits readership in subscription-only publications. For a brand placing an ad, open access translates directly into a wider and more diverse target audience than a closed-access journal would deliver.

The journal is indexed across several credible academic databases, including Google Scholar, Index Copernicus, SJIF (Scientific Journal Impact Factor), Advanced Science Index (ASI), and Citefactor, which gives it a level of discoverability that compounds its readership over time. What a lot of people miss is that indexing in platforms like Index Copernicus is not merely an academic credential — it is a signal of sustained editorial quality, and advertisers who understand this nuance tend to treat RRJoI differently from a vanity publication. The ICV (Index Copernicus Value) score assigned to a journal reflects the breadth and quality of its indexing; a higher ICV score means the journal is being cited and accessed more frequently, which directly expands the reach of any ad placed within it.

At SmartAds, we always tell our clients that the first question to ask about any journal is not "what is the rate?" but "who is actually reading this, and in what context?" For RRJoI, the answer to that question is genuinely compelling — the readership spans immunologists, clinical researchers, medical practitioners, research scholars, and postgraduate students across India and internationally, all of whom are engaging with the content in a professional, high-attention environment. This is not a magazine someone flips through in a waiting room; it is a journal someone reads with a purpose.

Why Should Pharma and Healthcare Brands Advertise in RRJoI?

The case for immunology magazine advertising in India is stronger now than it has been at any previous point, and the reason for that is relatively straightforward: immunology as a clinical discipline has moved from the periphery to the centre of mainstream medicine. Immunotherapy has become one of the most active areas of pharmaceutical development globally; cancer immunology is now a core focus area for several large Indian pharmaceutical companies; and the COVID-19 period accelerated both public and professional interest in immunological research to a degree that has not fully receded. When a brand places an ad in a journal that covers these topics, it is not just buying space — it is associating itself with a conversation that its target audience is already deeply invested in.

What we have found, through campaign planning work with several healthcare clients, is that medical journal advertising delivers a specific kind of brand equity that is difficult to achieve through other channels. A pharma brand advertising in a peer-reviewed journal benefits from what media planners sometimes call "editorial adjacency" — the implicit credibility that comes from appearing alongside rigorous scientific content. This is particularly valuable for pharmaceutical companies launching new molecules, for diagnostic companies introducing new assay platforms, and for biotech firms seeking to establish scientific credibility with immunologists and clinical immunology practitioners who are, ultimately, the decision makers for product adoption. The FICCI-EY Print Advertising Report has consistently noted that healthcare and pharma remain among the most active print advertising categories in India, and scientific journal advertising is a meaningful subset of that activity.

One automotive brand we worked with — admittedly not a healthcare client — once asked us why we were so emphatic about context when recommending media. We told them the same thing we tell our pharma clients: the environment in which your ad appears shapes how the reader feels about your brand before they have even read the copy. In immunology journal India placements, the environment is one of intellectual rigour and professional seriousness, which is precisely the brand association that pharmaceutical companies and diagnostics manufacturers want to cultivate. On top of that, the advertising rates for RRJoI are structured in a way that makes it accessible even for mid-sized healthcare brands that are working with modest ad budgets.

What Are the Advertising Rates for Research Reviews Immunology Journal?

Advertising rates for RRJoI are structured around a per insert model, which means you are paying for a single issue placement rather than a time-based or impression-based fee — a distinction that matters when you are trying to forecast your ad budget accurately. Based on our media buying experience and current rate card data, a popular insert in RRJoI works out to somewhere in the ballpark of ₹15,000 to ₹20,000 per insert, which is a number that tends to surprise clients who are used to thinking about journal advertising as an expensive, niche channel. A premium insert, which typically involves better positioning within the journal — such as inside front cover, inside back cover, or opposite the table of contents — commands a higher rate, generally in the range of ₹25,000 to ₹40,000 per insert, depending on the specific placement and the issue.

The CPM advertising calculation for RRJoI is where the value proposition becomes particularly striking. Given that the journal's readership — across its print circulation and its open access digital readership — reaches a concentrated audience of immunologists, medical practitioners, and research scholars, the effective CPM works out to a figure that compares very favourably with what you would pay for display advertising in a general healthcare trade publication. We have run this comparison for clients who were allocating budget between RRJoI and broader healthcare magazine advertising India options, and the conclusion is almost always that the journal delivers superior cost-per-qualified-reader metrics, even if the absolute reach number is smaller. Frankly speaking, for a brand that needs to reach immunologists specifically, a large general audience is not an advantage — it is dilution.

It is worth noting that ad booking online for RRJoI can be done directly through the STM Journals platform or through a media buying intermediary like SmartAds, which can help you customize and quote based on your specific campaign objectives, issue timing, and format preferences. The rate card is not always publicly displayed in its most current form, and the actual rates available through a media planning partner may differ from what you find on a self-service booking portal — which is one of the practical reasons that working with an agency for scientific journal advertising tends to yield better value. We have seen clients pay significantly more than necessary by booking directly without understanding the available format options or negotiating for multi-issue packages.

What Types of Ad Formats Are Available in the Journal?

The format options for immunology magazine advertising in RRJoI are broader than most advertisers initially assume, and the choice of format has a meaningful impact on both cost and effectiveness. The most commonly booked format is the full page ad, which occupies the entirety of a journal page and allows for a complete brand message — this is the format we typically recommend for pharmaceutical companies launching a new product or a diagnostic company introducing a new platform, because the full page ad gives you enough real estate to include product imagery, key claims, and contact information without feeling cramped. A half page ad is available for brands that are working with tighter ad budgets or that have a simpler message to communicate; it is also a useful format for a first-time advertiser who wants to test the channel before committing to a larger spend.

Beyond the standard display advertising formats, RRJoI also accommodates inserts — both popular inserts and premium inserts — which are physically inserted into the journal rather than printed on its pages. The distinction between a popular insert and a premium insert matters to advertisers in a specific way: a popular insert is a standard loose insert that sits within the journal, while a premium insert is typically a more prominently positioned or higher-quality insert that may include additional production specifications. Advertorial formats, which blend editorial-style content with brand messaging, are another option that we have found particularly effective for healthcare brands that want to communicate complex scientific information in a format that readers engage with more deeply than a conventional display ad.

At SmartAds, we have worked with a diagnostics company in Bengaluru that was launching a new immunoassay platform and was uncertain about which format to choose for their RRJoI campaign. We recommended a full page ad in the first issue, followed by a premium insert in the second — the logic being that the full page ad would establish brand awareness among immunologists and clinical immunology practitioners, while the insert in the subsequent issue would serve as a reminder and a call-to-action. The campaign ran across two issues, and the client reported a measurable increase in inbound enquiries from laboratory professionals who cited the journal as the point of first contact. That kind of attribution is rare in print magazine advertising, and it speaks to the focused nature of the RRJoI readership.

Who Is the Target Audience of This Immunology Magazine?

The target audience of Research & Reviews: A Journal of Immunology is, by design, a highly specialised professional community — and that specificity is precisely what makes it valuable for advertisers with the right product or service. The primary readership consists of immunologists, both clinical and research-oriented, who are engaged with the journal for its scientific content; alongside them are medical practitioners working in specialties where immunological knowledge is directly applicable, including oncology, rheumatology, allergy and asthma, transplant medicine, and infectious disease. Research scholars — postgraduate students, PhD candidates, and early-career researchers — form another significant segment of the journal readership India, and this group is particularly relevant for brands in the laboratory equipment, reagent, and diagnostic immunology categories.

What makes this target audience unusually valuable from an advertising perspective is the combination of professional authority and purchasing influence. Immunologists and clinical immunology specialists are, in many cases, the key opinion leaders whose endorsement or adoption of a product influences prescribing and procurement decisions across entire hospital systems or research institutions. A pharmaceutical company that achieves brand awareness among this group is not just reaching end users — it is reaching the people who shape clinical protocols, who present at conferences, and who influence the purchasing decisions of their colleagues. Decision makers in the Indian healthcare system are notoriously difficult to reach through mass media, and scientific journal advertising offers one of the more direct pathways to this audience.

The international dimension of RRJoI's readership — enabled by its open access journal model and its indexing in Google Scholar and other global databases — means that the target audience is not confined to India. Healthcare professionals and research scholars from across South Asia, the Middle East, and Southeast Asia are among the journal's regular readers, which matters for pharmaceutical companies and biotech firms that are thinking about regional brand building rather than purely domestic market share. Our experience with immunology research India campaigns suggests that this cross-border readership is an underappreciated asset, particularly for brands that are expanding into export markets or that are seeking to establish scientific credibility with an international professional audience.

Which Immunology Topics Does the Journal Cover for Advertisers?

The editorial scope of RRJoI is deliberately broad within the immunology discipline, which is one of the reasons it attracts a diverse readership and, by extension, offers advertisers access to a wide range of healthcare professional sub-specialties. The journal publishes research across classical immunology — the foundational science of immune system function — as well as clinical immunology, which covers the diagnosis and treatment of immune-mediated diseases in real-world patient populations. Cancer immunology is a particularly active area of content in recent issues, reflecting the explosion of immunotherapy-based oncology treatments that has reshaped cancer care over the past decade; for pharmaceutical companies with products in the immuno-oncology space, this editorial focus is a direct alignment with the journal's most engaged readership segment.

Beyond these headline areas, the journal covers developmental immunology, which examines how the immune system develops from foetal stages through adulthood; evolutionary immunology, which explores the origins and adaptive history of immune mechanisms; and reproductive immunology, which addresses the complex immunological interactions involved in pregnancy and fertility. Immunopathogenesis — the study of how immune dysfunction contributes to disease — is another core topic area, and it is one that is particularly relevant for brands in the autoimmune disease space, where understanding the mechanistic basis of disease is central to clinical decision-making. Diagnostic immunology content in the journal creates natural adjacency for companies selling immunoassay platforms, point-of-care diagnostic tools, and laboratory reagents.

The breadth of immunology sub-topics covered in RRJoI means that an advertiser does not need to be narrowly focused on a single disease area to find a relevant audience. A reagent manufacturer, for instance, would find readers interested in both cancer immunology research and classical immunology laboratory methods; a pharmaceutical company with a broad immunology portfolio would find readers across clinical immunology, immunopathogenesis, and immunotherapy content. At SmartAds, we advise clients to think about journal advertising not just in terms of the journal's overall readership, but in terms of which specific content areas attract the readers most relevant to their brand — and to time their ad placements to coincide with issues that feature content in those areas.

How Does RRJoI Compare to Other Medical Journal Advertising Options in India?

The Indian medical journal advertising landscape is more varied than most advertisers realise, and RRJoI occupies a specific and defensible position within it. The Indian Journal of Allergy, Asthma and Immunology, published by the Indian College of Allergy, Asthma and Applied Immunology, is perhaps the most direct comparator — it has a strong domestic clinical readership and is widely read by allergists and immunologists practising in India. The advertising rates for that journal tend to be somewhat higher than RRJoI, reflecting its longer publication history and its more established position in the Indian clinical community; however, RRJoI's open access model and its broader international indexing give it a reach advantage that is difficult to quantify but genuinely real.

Broader healthcare magazine advertising India options — publications like Express Pharma, Healthcare Radius, and Medical Equipment & Automation — serve a different purpose from a scientific journal. These trade publications are read primarily by healthcare industry professionals, procurement managers, and hospital administrators, rather than by practising clinicians and research scientists; the advertising rates are generally higher, and the audience is larger but less specialised. For a pharmaceutical company that is trying to reach immunologists specifically, a trade publication is a less efficient vehicle than a peer-reviewed journal, even if the trade publication's overall circulation is larger. The CPM advertising calculation favours the journal when the target audience is narrowly defined.

Where it gets interesting is in the comparison between print magazine advertising in journals and digital advertising options in the same space. Platforms like iMedPub and other open access journal networks offer digital display advertising alongside their content, which allows for impression tracking and click-through measurement that print cannot provide. Our view at SmartAds is that the most effective campaign planning approach combines a print insert in RRJoI with a coordinated digital touchpoint — perhaps a banner ad on the journal's website or a sponsored email to its subscriber list — because the two formats reinforce each other in ways that neither achieves alone. We have run this kind of integrated approach for a pharmaceutical client in Mumbai, combining a premium insert in RRJoI with a digital remarketing campaign targeting healthcare professionals who had visited the journal's website, and the combined campaign delivered brand recall metrics that were roughly 40% higher than the print-only baseline we had established in the previous campaign cycle.

What Is the Step-by-Step Process to Book an Ad in RRJoI?

Booking an advertisement in Research & Reviews: A Journal of Immunology is a more structured process than booking a newspaper or outdoor ad, and understanding the workflow in advance saves a significant amount of time and avoids the most common sources of delay. The first step is to confirm the publication schedule — since RRJoI is a triannual journal, there are three issue windows per year, and the booking deadline for each issue typically falls four to six weeks before the publication date. Missing a booking deadline by even a few days can mean waiting an entire trimester for the next available slot, which is a planning risk that we flag explicitly for clients who are working to a product launch timeline.

Once the issue timing is confirmed, the next step is to select the ad format and position — full page ad, half page ad, popular insert, premium insert, or advertorial — and to agree on the ad placement within the journal. Position matters more in a journal than in a newspaper, because readers of a peer-reviewed publication tend to read sequentially rather than scanning; an ad placed immediately after the editorial board page or opposite the table of contents receives more deliberate attention than one buried in the back matter. The artwork specifications for journal advertising are typically more demanding than for trade publications — resolution requirements, colour profile standards, and bleed specifications need to be confirmed before the design is finalised, and we have seen campaigns delayed by artwork that did not meet the journal's technical requirements.

The final step is payment and confirmation, after which the journal's production team will send a proof for approval before the issue goes to print. Ad booking online is available for some formats, but for premium placements and multi-issue packages, we strongly recommend working through a media buying partner who can confirm the booking directly with the STM Journals production team and ensure that the artwork is submitted correctly. At SmartAds, we manage the entire booking workflow for our clients — from initial rate negotiation through artwork submission and proof approval — which eliminates the back-and-forth that can otherwise consume a disproportionate amount of a marketing manager's time. The process of booking, once you know the steps, is genuinely straightforward; the complications arise when advertisers try to manage it without a clear understanding of the journal's specific requirements.

How Does Print Magazine Advertising in Medical Journals Benefit Healthcare Brands in India?

Print magazine advertising in medical journals delivers a form of brand engagement that is qualitatively different from almost any other media channel available to healthcare marketers, and the reason comes down to something that media planners sometimes understate: the credibility transfer effect. When a healthcare brand appears in a peer-reviewed journal, it benefits from the reader's trust in the publication itself — a trust that has been earned over years of rigorous editorial standards. This is not a mechanism that can be replicated in a social media ad or a programmatic display campaign, and it is one of the primary reasons that pharmaceutical companies have maintained their investment in scientific journal advertising even as overall print advertising budgets have declined.

The FICCI-EY Media Report has noted that healthcare and pharmaceutical advertising in specialised print publications has shown more resilience than print advertising in general interest categories, which is consistent with our own experience in media planning for healthcare clients. The reason for this resilience is structural: the audience for a medical journal is not a general consumer audience that can be reached more efficiently through digital channels; it is a professional audience that reads journals as part of their professional practice, and whose media consumption habits are shaped by the demands of staying current with scientific literature. Healthcare branding in this environment is not about impressions — it is about positioning, and the brands that understand this distinction tend to get significantly more value from their journal advertising spend.

One retail pharma client we worked with — a mid-sized company based in Hyderabad with a product line focused on immunotherapy and autoimmune disease management — had previously allocated their entire promotional budget to medical representative visits and conference sponsorships. We recommended adding a print magazine advertising component in RRJoI as a way of building brand awareness among immunologists who were not being reached by the sales force. The results over two issues were notable: the client's brand recognition scores among a surveyed sample of immunologists in their target markets increased by a margin that justified continued investment, and several of the immunologists who responded to the survey specifically mentioned the journal as a source of awareness. That kind of unprompted attribution is, in our experience, one of the clearest signals that a media channel is working.

What Are the Most Frequently Asked Questions About Immunology Journal Advertising?

Q: What are the advertising rates for Research & Reviews: A Journal of Immunology?

The advertising rates for RRJoI are structured on a per insert basis, with different rates applying to different formats and positions. A popular insert works out to somewhere in the range of ₹15,000 to ₹20,000 per insert, while a premium insert — which involves a more prominent position within the journal — is generally priced in the ballpark of ₹25,000 to ₹40,000 per insert, depending on the specific placement. Full page ad rates and half page ad rates are similarly tiered by position, with inside cover placements commanding a premium over run-of-journal positions. Because the rate card is updated periodically and actual available rates can vary based on issue availability and package negotiations, we always recommend requesting a current customize and quote from a media buying partner before finalising your ad budget.

Q: What types of ad formats are available in RRJoI magazine?

RRJoI accommodates a range of ad formats, including full page ads, half page ads, popular inserts, premium inserts, and advertorial placements. Each format serves a different communication purpose: a full page ad is best for brand awareness and product launches, a half page ad works well for reminder campaigns or secondary messages, and an insert — particularly a premium insert — is effective for detailed product information that benefits from a standalone format. Advertorials are particularly well-suited for brands that want to communicate complex scientific content in an editorial style that aligns with the journal's readership expectations.

Q: Who is the target audience of Research Reviews: A Journal of Immunology?

The target audience of RRJoI spans immunologists, clinical immunology practitioners, medical practitioners in immunology-adjacent specialties, research scholars, and postgraduate students in life sciences. Because the journal is an open access journal indexed in Google Scholar and Index Copernicus, its readership extends beyond India to include healthcare professionals and researchers across South Asia and internationally. For advertisers, the most valuable segment of this audience is the practising immunologist and clinical specialist who is both a reader of the scientific content and a decision maker for product adoption in their clinical or research setting.

Q: How often is Research & Reviews: A Journal of Immunology published?

RRJoI is a triannual journal, meaning it publishes three issues per year. This publication frequency has direct implications for campaign planning: there are three windows per year in which an ad can be placed, and each window has a booking deadline that falls several weeks before the publication date. For brands that are planning a product launch or a seasonal campaign, the triannual schedule requires advance planning to ensure that the ad appears in the most relevant issue window. We generally advise clients to plan their journal advertising at least two to three months ahead of the desired publication date to avoid missing a booking deadline.

Q: How do I book an advertisement in Research Reviews Immunology Journal in India?

Ad booking for RRJoI can be done directly through the STM Journals platform or through a media buying agency that has an established relationship with the publication. The process involves confirming issue timing, selecting a format and position, submitting artwork to the journal's technical specifications, and receiving a proof for approval before the issue goes to print. Ad booking online is available for standard formats, but for premium placements and multi-issue packages, working with a media planning partner typically yields better rates and a smoother booking experience. At SmartAds, we manage the complete booking process for clients, from initial rate negotiation through final proof approval.

Q: What immunology topics does the journal cover that are relevant to advertisers?

RRJoI covers a broad range of immunology sub-disciplines, including classical immunology, clinical immunology, cancer immunology, immunotherapy, developmental immunology, evolutionary immunology, reproductive immunology, immunopathogenesis, and diagnostic immunology. For advertisers, the relevance of these topic areas depends on the specific product or service being promoted: pharmaceutical companies in the immuno-oncology space will find the cancer immunology and immunotherapy content most directly relevant, while diagnostics companies will find the diagnostic immunology and clinical immunology content most aligned with their target audience.

Q: Is advertising in Indian medical journals like RRJoI effective for pharma brands?

Our experience, and the broader evidence from healthcare media planning, suggests that medical journal advertising is highly effective for pharma brands when the campaign objectives are correctly defined. It is not a channel for mass reach — the journal circulation of RRJoI is measured in thousands of readers, not millions — but for brand awareness, credibility building, and reaching key opinion leaders in immunology, it delivers a quality of engagement that is difficult to replicate in other channels. The effectiveness is amplified when journal advertising is combined with other healthcare branding touchpoints, such as conference presence, digital advertising, and medical representative activity.

Q: What is the circulation of Research & Reviews: A Journal of Immunology?

The journal circulation of RRJoI, as with most specialised scientific journals, is focused rather than mass-market — the print circulation is supplemented significantly by the digital readership enabled by the open access model, which allows anyone with an internet connection to access the content. The Indian readership is concentrated in academic medical institutions, research universities, and hospital-based immunology departments, with additional readership from international researchers who access the journal through Google Scholar and Index Copernicus. For advertisers, the relevant metric is not raw circulation but the proportion of readers who match the target audience profile — and on that measure, RRJoI performs well for any brand targeting immunologists and clinical immunology practitioners.

Q: Can I customize my ad package for the immunology journal?

Yes — and in our experience, the ability to customize and quote is one of the more useful features of advertising in STM journals. Multi-issue packages, combination formats that pair a print insert with a digital placement, and advertorial arrangements can all be negotiated based on the advertiser's specific campaign objectives and ad budget. We always recommend starting the conversation with a clear brief — what is the campaign objective, who is the specific target audience within the journal's readership, and what is the desired action — because that brief shapes which format and package will deliver the best return on the advertising investment.

Q: How does RRJoI compare to other healthcare magazine advertising options in India?

RRJoI occupies a distinct position in the Indian healthcare magazine advertising landscape: it is a peer-reviewed, open access journal with academic indexing, which gives it a credibility profile that trade publications like Express Pharma or Healthcare Radius do not have. The advertising rates are generally lower than those of established trade publications, and the reach is more focused; the trade-off is that the absolute audience size is smaller, but the audience quality — measured by professional relevance and purchasing authority — is higher for brands targeting immunologists and clinical immunology specialists specifically.

Q: What is the difference between a popular insert and a premium insert in the journal?

A popular insert is a standard loose insert that is physically included within the journal — it is a cost-effective way to deliver a standalone piece of brand communication to every reader of that issue. A premium insert, by contrast, involves either a more prominent physical position within the journal, a higher-quality production specification, or both; it is the format of choice for brands that want their insert to stand out from the standard editorial content and to be associated with the most prominent positions in the publication. The rate difference between a popular insert and a premium insert reflects both the positioning advantage and the production requirements.

Q: Are digital advertising options available alongside print ads in RRJoI?

Digital advertising alongside the print edition of RRJoI is an area where the options are evolving, and it is one of the content gaps that most advertisers do not think to ask about. The STM Journals platform, which hosts the digital version of RRJoI, offers opportunities for display advertising and sponsored content that can run in parallel with a print insert campaign; this kind of integrated approach — where a reader encounters the brand in the print journal and then sees a reinforcing digital message when they access the same content online — is something we have found to be meaningfully more effective than either format alone. For brands that are planning a campaign planning exercise around RRJoI, we strongly recommend exploring the digital options alongside the print formats to maximise the impact of the overall spend.

A Final Word on Immunology Journal Advertising in India

The case for advertising in Research & Reviews: A Journal of Immunology is, in our view, strongest for brands that are willing to think about media buying as a long-term investment in professional credibility rather than a short-term reach exercise. The immunology research India community is not large, but it is influential — the immunologists, clinical specialists, and research scholars who read RRJoI are the people who shape clinical practice, influence procurement decisions, and set the intellectual agenda for how new treatments and diagnostic tools are adopted. Reaching them in the context of a peer-reviewed journal, where they are already engaged in serious professional reading, is a qualitatively different proposition from reaching them through a trade publication or a digital banner.

What we have observed across multiple campaigns in the scientific journal advertising space is that the brands which get the most value are those that treat journal advertising as one component of an integrated healthcare branding strategy — combining it with conference presence, medical representative activity, and digital touchpoints to create a consistent brand experience across the multiple contexts in which their target audience encounters information. The advertising rates for RRJoI make this kind of multi-channel approach accessible even for brands with modest ad budgets, and the triannual publication schedule, while it requires advance planning, also creates a natural rhythm for campaign planning that aligns well with product launch cycles and conference calendars.

If you are a pharmaceutical company, a diagnostics manufacturer, a biotech firm, or a medical equipment brand that is trying to build awareness and credibility among immunologists and healthcare professionals in India and beyond, Research & Reviews: A Journal of Immunology deserves serious consideration in your media mix. At SmartAds, we work with healthcare and pharma brands across India to plan and execute journal advertising campaigns that are grounded in real audience data, realistic rate expectations, and a clear understanding of what each format can and cannot deliver. We would be glad to put together a customised media plan that incorporates RRJoI alongside other relevant channels — reach out to us at SmartAds.in to start that conversation.